Radioimmunotherapy using .alpha.-particles emission

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

534 10, A61K 4300, C07F 1700

Patent

active

052466914

ABSTRACT:
The present invention relates to the use of Actinium or one of its daughters in radioimmunotherapy. Also provided are immunoconjugates comprising an isotope, a chelating agent and a slowly localizing antibody. The invention also includes pharmaceutical compositions comprising said immunoconjugates, as well as such compositions comprising one or more scavenging agents. The compositions according to the invention are particularly useful for the treatment of micrometastases in adjuvant therapy, as well as for treatment of localized tumors.

REFERENCES:
patent: 4454106 (1984-06-01), Gansow et al.
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4816397 (1989-03-01), Boss et al.
patent: 4828991 (1989-05-01), Hanna et al.
patent: 4923985 (1990-05-01), Gansow et al.
Scheinberg et al, "Targeting in Erythroleukemic Mice . . . ," Monoclonal Antibodies Drug Dev., Process John Jacob Abel Symp. for Drug Dev. 1982, pp. 159-171.
"Astatine-211: It's Possible Applications in Cancer Therapy", Brown, International Journal of Radiation Applications and Instrumentation Part A, vol. 37, No. 8, pp. 789-798 (1986).
"Preparation of .sup.224 Ra for Therapy of Ankylosing Spondylitis", Delikan Health Physics, vol. 35, No. 1, pp. 21-24 (1978).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Radioimmunotherapy using .alpha.-particles emission does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radioimmunotherapy using .alpha.-particles emission, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmunotherapy using .alpha.-particles emission will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1048053

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.